Survival after treatment for breast cancer in a geographically defined population

British Journal of Surgery

Volumn 91, Issue 10, 2004, Pages 1307-1312

  Tejler, G ^a,d   Norberg, B ^b   Dufmats, M ^c   Nordenskjold B ^c  

^a Vastervik Hospital   (Sweden)

^b Jonkoping Hospital   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^d Department of Internal Medicine   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; TAMOXIFEN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; CANCER THERAPY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GEOGRAPHY; HEALTH PROGRAM; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PARTIAL MASTECTOMY; POPULATION RESEARCH; POSTOPERATIVE CARE; PRIORITY JOURNAL; SEGMENTAL MASTECTOMY; SURGICAL TECHNIQUE; SURVIVAL RATE; SWEDEN;

ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; ENGLAND; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; WALES;

EID: 4944254361     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4697     Document Type: Article

References (26)

1. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Cancer mortality in Europe, 1990-1994, and an overview of trends from 1955 to 1994. Eur J Cancer 1999; 35: 1477-1516.
2. Levi F, Lucchini F, Negri E, La Vecchia C. The decline in cancer mortality in the European Union, 1988-1996. Eur J Cancer 2000; 36: 1965-1968.
3. Peto R, Boreham J, Clarke M, Davies C, Beral V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 2000; 335: 1822.
4. Persson I, Bergström R, Sparén P, Thörn M, Adami HO. Trends in breast cancer incidence in Sweden 1958-1988 by time period and birth cohort. Br J Cancer 1993; 68: 1247-1253.
5. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of randomised trials. Lancet 1998; 352: 930-942.
6. The National Board of Health and Welfare. Centre for Epidemiology: Stockholm, 2001.
7. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984; 23: 305-313.
8. Garne JP, Aspegren K, Møller T. Validity of breast cancer registration from one hospital into the Swedish National Cancer Registry 1971-1991. Acta Oncol 1995; 34: 153-156.
9. Lagerlund M. Socioeconomic factors and breast cancer survival - a population-based cohort study in Sweden. Karolinska Institute, Stockholm University, 2002 [Dissertation].
10. The National Board of Health and Welfare. Centre for Epidemiology: Stockholm, 2000.
11. Tabar L, Gad A, Holmberg LH, Ljungquist U, Fagerberg CJ, Baldetorp L et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985; i: 829-832.
12. Arnesson L-G, Vitak B, Månsson J-C, Fagerberg G, Smeds S. Diagnostic outcome in repeated mammography screening. World J Surg 1995; 19: 372-378.
13. Stål O, Brisfors A, Carstensen J, Ferraud L, Hatschek T, Nordenskjöld B and the South-East Sweden Breast Cancer Group. Relationships of DNA ploidy, S-phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening. Int J Cancer 1992; 51: 28-33.
14. Swedish Breast Cancer Cooperative Group. Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. J Natl Cancer Inst 1996; 88: 1543-1549.
15. Baum M, Rutgers EE on behalf of the ZIPP trial. Zoladex and tamoxifen as adjuvant therapy in premenopausal breast cancer: a randomised trial by the Cancer Research Campaign (CRC) Breast Cancer Trials Group, the Stockholm Breast Cancer Study Group, the South-East Swedish Breast Cancer Group and the Gruppo Interdiciplinara Valutazlone Intervend in Oncologia (GIVIO). Breast 1999; 8: 233 (Abstract 070).
16. Levine MN, Bramwell VH, Pritchard KI, Norris BD, Shepard LE, Abu-Zahra H et al. Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1998; 16: 2651-2658.
17. Mouridsen HT, Andersen J, Andersson M, Dombernowsky P, Ejlertsen B, Rose C et al. Adjuvant anthracycline in breast cancer. Improved outcome in premenopausal patients following substitution of methotrexate in the CMF combination with epirubicin. Eur J Cancer 1999; 35(Suppl): S83 (Abstract 270).
18. Halculinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38: 933-942.
19. Sainsbury R, Haward B, Rider L, Johnston C, Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 1995; 345: 1265-1270.
20. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F et al for the Danish Breast Cancer Cooperative Group 82b Trial. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997; 337: 949-955.
21. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patient given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 83c randomised trial. Lancet 1999; 353: 1641-1648.
22. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998; 351: 1451-1467.
23. Quinn M, Allen E on behalf of the United Kingdom Association of Cancer Registries. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. BMJ 1995; 311: 1391-1395.
24. dos Santos Suva I, Mangtani P, De Stavola BL, Bell J, Quinn M, Mayer D. Survival from breast cancer among South Asian and non-South Asian women resident in South East England. Br J Cancer 2003; 89: 508-512.
25. Quinn MJ, Marrinez-Garcia C, Berrino F and the EUROCARE Working Group. Variations in survival of breast cancer in Europe by age and country, 1978-1989. Eur J Cancer 1998; 34(14 special no.): 2204-2211.
26. Carter CL, Allen C, Henson D. Relation of tumor size, lymph node status, and survival in 24 740 breast cancer cases. Cancer 1989; 63: 181-187.